The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...
GoodRx and pharmacy benefit managers CVS Caremark, Express Scripts, MedImpact and Navitus Health Solutions are facing class-action lawsuits accusing them of colluding to super press reimbursements to ...
Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...
The pharmacy benefit managers, which were named in two of the complaints—CVS Caremark, Express Scripts, MedImpact, and ...
Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...
When asked about restrictions on supportive care medications, a spokesman for CVS Caremark, one of the nation’s largest ...
The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...
Express Scripts said the legal action was "reckless ... chief legal officer at Cigna. CVS Caremark said that preventing PBMs from negotiating drug prices will only benefit pharma companies ...
The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.
But today, according to the Federal Trade Commission, the six largest PBMs — CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics and MedImpact — manage nearly 95% of all prescriptions ...
Those companies are: * Caremark Rx, which is owned by CVS Health. * Express Scripts which is subsidiary of Cigna. * OptumRx, which is owned by UnitedHealth. Angela Mattie, a professor of ...